Medizone Biotech Private Limited

Medizone Biotech Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2013PTC261733 Incorporated 06 December 2013 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹52.09 Lakh
▲ 15% YoY
Net profit · FY 2025
₹56,133
Net margin 1.1%
EBITDA · FY 2025
₹1.46 Lakh
EBITDA margin 2.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Medizone Biotech Private Limited

Data last updated:

Medizone Biotech Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 December 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2013PTC261733. Its GSTIN is 07AAICM9547K1ZT (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajender Kumar Munday and Ruby Munday.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 97 1st Floor K. No – 710 Gali No – 2 Sadat Pur Ext. Karawal N, Agar Road, Delhi, India – 110094.

As per the financials filed for FY 2025, the company reported a revenue of ₹52.09 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹56,133 (net margin 1.1%) and EBITDA of ₹1.46 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 14% over five years.

Medizone Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0007156). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999DL2013PTC261733
Registration Number 261733
Incorporation Date 06 December 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-05-0007156

Recognitions & Rankings of Medizone Biotech

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-05-0007156

Contact details

Medizone Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B – 97 1st Floor K. No – 710 Gali No – 2 Sadat Pur Ext. Karawal N, Agar Road, Delhi, India – 110094
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Medizone Biotech Private Limited, buy the company report.

Comprehensive company report
Medizone Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medizone Biotech is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Medizone Biotech Private Limited, buy the company report.

Financials of Medizone Biotech Private Limited

FY 2025 filings available

Medizone Biotech Private Limited reported revenue of ₹52.09 Lakh (up 15% YoY) for FY 2025.

Revenue · FY 2025
₹52.09 Lakh ▲ 15%
Net profit · FY 2025
₹56,133 margin 1.1%
EBITDA · FY 2025
₹1.46 Lakh margin 2.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 29%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 52%
5 years · compounded
▲ 43%

Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 15% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.46 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹56,133
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.8%
Net Profit Margin1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medizone Biotech Private Limited, buy the company report.

Board of directors of Medizone Biotech Private Limited

Medizone Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajender Kumar MundayDirector06 Dec 201312 Years 11 MonthsCurrent
Ruby MundayDirector07 Jul 201511 Years 4 MonthsCurrent

Auditor

Medizone Biotech Private Limited is audited by VINEET SANDESH & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
VINEET SANDESH & ASSOCIATESFY 2023020885N

Shareholding

The shareholding of Medizone Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medizone Biotech Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medizone Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medizone Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAICM9547K1ZTDelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Medizone Biotech Private Limited, buy the company report.

Recent activity

Medizone Biotech Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Ruby Munday was appointed as Director on 07 Jul 2015.

AGM
Medizone Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medizone Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Ruby Munday was appointed as Director.
Ceased
Sonu Kumar ceased to be Director.
Appointed
Rajender Kumar Munday was appointed as Director.
Incorporation
06 Dec 2013
Medizone Biotech Private Limited was registered on 06 Dec 2013 with Roc Delhi & aged 12 years 11 months as per MCA records.

Frequently asked questions

Medizone Biotech is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 December 2013 (13+ years old) and is registered under CIN U74999DL2013PTC261733.

Medizone Biotech has 2 current directors:

The latest financial statements of Medizone Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Medizone Biotech is 07AAICM9547K1ZT, registered in Delhi.

The CIN (Corporate Identification Number) of Medizone Biotech is U74999DL2013PTC261733. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medizone Biotech was incorporated on 06 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.

Ruby Munday was appointed as Director on 07 Jul 2015. Sonu Kumar ceased to be Director on 07 Jul 2015. Rajender Kumar Munday was appointed as Director on 06 Dec 2013.

Yes, Medizone Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-05-0007156).

The registered office of Medizone Biotech is at B – 97 1st Floor K. No – 710 Gali No – 2 Sadat Pur Ext. Karawal N, Agar Road, Delhi, India – 110094.

Medizone Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.